Carditis After COVID-19 Vaccination With a Messenger RNA Vaccine and an Inactivated Virus Vaccine : A Case-Control Study.

ABSTRACT:

Background

Case reports of carditis after BNT162b2 vaccination are accruing worldwide.

Objective

To examine the association of BNT162b2 and CoronaVac (Sinovac) vaccination with carditis.

Design

Case-control study with hospital control participants.

Setting

Territory-wide, public health care database with linkage to population-based vaccination records in Hong Kong.

Patients

Inpatients aged 12 years or older first diagnosed with carditis were selected as case patients. All other hospitalized patients without carditis were treated as control participants. Ten control participants were randomly matched with each case patient by age, sex, and admission date.

Intervention

Vaccination with BNT162b2 or CoronaVac.

Measurements

Incident diagnosis of

SUBMITTER: Lai FTT 

PROVIDER: S-EPMC8814917 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature